Bookbot
Je koopt precies het boekdat op de foto staat

A Lippincott Williams & Wilkins Handbook: Handbook of Cancer Chemotherapy - Seventh Edition

Parameters

  • 817bladzijden
  • 29 uur lezen

Meer over het boek

The Seventh Edition of this pocket reference is a practical, disease-focused guide to the best current medical practice in cancer chemotherapy. In easy-to-follow outline format, the book provides complete coverage of the principles of rational chemotherapy, the chemotherapeutic and biotherapeutic agents available, the treatment of specific cancers, and selected aspects of supportive care. Emphasis is on the indications, dosage/schedule, potential toxicities, and safe administration of the drugs and their use in treating specific malignancies. This edition describes seventeen new chemotherapeutic agents, with particular attention to molecular targeted agents. Updated chapters on individual cancers and supportive care provide state-of-the-art treatment recommendations.

Een boek kopen

A Lippincott Williams & Wilkins Handbook: Handbook of Cancer Chemotherapy - Seventh Edition, Roland T. Skeel

Taal
Jaar van publicatie
2007
Bindwijze
(Paperback),
Staat van het boek
Goed
Prijs
€ 9,99

Betaalmethoden

Nog niemand heeft beoordeeld.

Titel
A Lippincott Williams & Wilkins Handbook: Handbook of Cancer Chemotherapy - Seventh Edition
Taal
Engels
Jaar van publicatie
2007
Formaat
Paperback
Aantal pagina's
817
ISBN10
0781765315
ISBN13
9780781765312
Reeks
Aantekening
The Seventh Edition of this pocket reference is a practical, disease-focused guide to the best current medical practice in cancer chemotherapy. In easy-to-follow outline format, the book provides complete coverage of the principles of rational chemotherapy, the chemotherapeutic and biotherapeutic agents available, the treatment of specific cancers, and selected aspects of supportive care. Emphasis is on the indications, dosage/schedule, potential toxicities, and safe administration of the drugs and their use in treating specific malignancies. This edition describes seventeen new chemotherapeutic agents, with particular attention to molecular targeted agents. Updated chapters on individual cancers and supportive care provide state-of-the-art treatment recommendations.